Practical Management of VTE: Simplifying Prophylaxis
Back to course
Video Transcription
Hello, it's my pleasure to be able to speak to you today about the real-world anticoagulation
practice in venous thromboembolism. My name is Teresa Carmen. I'm from University Hospitals Case Medical Center. I have no disclosures relevant to this topic and I'm going to avoid
off-label discussions of the anticoagulants. Today, I want to make sure we understand and recognize the need for an individual patient-centered management plan for patients with
venous thromboembolism. Not all VTE is created equal. I'm going to help us develop an algorithm
for comprehensive patient evaluation and to get us started on choosing our anticoagulants, we're
going to discuss how comorbidities may influence the choice of anticoagulants that we're going to
use. So venous thromboembolism is a spectrum of disease. We can range from pulmonary embolism, which may be massive or clinically relevant and with high clinical risk,
isolated internal jugular vein thrombosis, or even IBC filter thrombosis. In addition, we have
other types of venous thromboembolism, such as distal VVT or Padgett-Schroeder syndrome and
incidental PE. And all of these patients with venous thromboembolism are not created equal
and they all need an individual assessment and management plan. Now, there are different levels
of management. Usual management would consist of clinical assessment, imaging for diagnosis,
anticoagulation. We may search for a reason why and then we discharge the patient for follow-up.
I think, however, we need to get past that and go to a higher level of management using our
risk prediction tools, our biomarker support for diagnosis and management. Start anticoagulation
while we consider the diagnosis of venous thromboembolism and then do our imaging that may be appropriate. When we talk about anticoagulation for treatment, it needs to be
Video Summary
In this video, Dr. Teresa Carmen discusses the management of venous thromboembolism (VTE). She emphasizes the need for an individualized patient-centered approach, as not all VTE cases are the same. Dr. Carmen suggests using risk prediction tools and biomarkers for diagnosis and management. She also discusses the choice of anticoagulant therapy, taking into consideration comorbidities and the need for interventions. Dr. Carmen notes that anticoagulants should be started as soon as VTE is suspected, even before definitive testing is done. She discusses the diagnostic tests commonly used, such as duplex ultrasound, CTA, and VQ scan. Dr. Carmen also provides recommendations for the choice of anticoagulant therapy based on different patient scenarios and comorbidities. She highlights the importance of patient education, follow-up, and management of post-VTE events. Finally, she discusses the implications of factors like obesity, chronic kidney disease, liver disease, bariatric surgery, and cancer on the choice of anticoagulants.
venous thromboembolism
individualized approach
anticoagulant therapy
diagnostic tests
patient education
Android App Download IOS App Download Powered By